Home › Asset managers › Compare 2025-2026 › John Hancock vs Brighthouse
Note on Brighthouse: its funds did not all vote the same way on 12.0% of the 120,248 ballot items it voted. Those items are not in the percentage above; the ones it shares with this pair are listed under “Split votes”.
John Hancock 2025-2026 · Brighthouse 2025-2026 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 23,447 | 16,121 | 375 | 6,951 | 97.7% | 87.2% |
| Board proposals | 19,371 | 12,912 | 325 | 6,134 | 97.5% | 86.8% |
| E&S shareholder proposals | 161 | 0 | 0 | 161 | n/a | 38.1% |
| Other items | 3,915 | 3,209 | 50 | 656 | 98.5% | 91.5% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
6,134 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | John Hancock | Brighthouse |
|---|---|---|---|---|---|---|
| ARCOSA, INC. | May 13, 2026 | Election of nine (9) Directors to serve on the Board Antonio Carrillo Director Elections |
Board | For | FOR 8 funds |
Split 1 FOR, 1 ABSTAIN |
| ARCOSA, INC. | May 13, 2026 | Election of nine (9) Directors to serve on the Board Jeffrey A. Craig Director Elections |
Board | For | FOR 8 funds |
Split 1 FOR, 1 ABSTAIN |
| ARCOSA, INC. | May 13, 2026 | Election of nine (9) Directors to serve on the Board John W. Lindsay Director Elections |
Board | For | FOR 8 funds |
Split 1 FOR, 1 ABSTAIN |
| ARCOSA, INC. | May 13, 2026 | Election of nine (9) Directors to serve on the Board Joseph Alvarado Director Elections |
Board | For | FOR 8 funds |
Split 1 FOR, 1 ABSTAIN |
| ARCOSA, INC. | May 13, 2026 | Election of nine (9) Directors to serve on the Board Julie A. Piggott Director Elections |
Board | For | FOR 8 funds |
Split 1 FOR, 1 ABSTAIN |
| ARCOSA, INC. | May 13, 2026 | Election of nine (9) Directors to serve on the Board Kimberly S. Lubel Director Elections |
Board | For | FOR 8 funds |
Split 1 FOR, 1 ABSTAIN |
| ARCOSA, INC. | May 13, 2026 | Election of nine (9) Directors to serve on the Board Melanie M. Trent Director Elections |
Board | For | FOR 8 funds |
Split 1 FOR, 1 ABSTAIN |
| ARCOSA, INC. | May 13, 2026 | Election of nine (9) Directors to serve on the Board Rhys J. Best Director Elections |
Board | For | FOR 8 funds |
Split 1 FOR, 1 ABSTAIN |
| ARCOSA, INC. | May 13, 2026 | Election of nine (9) Directors to serve on the Board Steven J. Demetriou Director Elections |
Board | For | FOR 8 funds |
Split 1 AGAINST, 1 ABSTAIN |
| ARCOSA, INC. | May 13, 2026 | Ratification of Ernst & Young LLP as Arcosa's independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | FOR 8 funds |
Split 6 FOR, 1 ABSTAIN |
| ARCUS BIOSCIENCES, INC. | June 11, 2026 | To approve, on an advisory basis, the compensation of Arcus Biosciences' named executive officers, as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | FOR 5 funds |
Split 2 FOR, 1 ABSTAIN |
| ARCUS BIOSCIENCES, INC. | June 11, 2026 | To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of Arcus Biosciences for its fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 3 funds |
Split 2 FOR, 1 ABSTAIN |
| ARCUTIS BIOTHERAPEUTICS, INC. | June 5, 2026 | Election of Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected. Patrick J. Heron Director Elections |
Board | For | WITHHOLD 3 funds |
Split 1 FOR, 2 WITHHOLD |
| ARCUTIS BIOTHERAPEUTICS, INC. | June 5, 2026 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 5 funds |
Split 2 FOR, 1 ABSTAIN |
| ARCUTIS BIOTHERAPEUTICS, INC. | June 5, 2026 | To ratify the selection, by the Audit Committee of the Company's Board of Directors, of Ernst & Young LLP, as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 3 funds |
Split 2 FOR, 1 ABSTAIN |
| ARDELYX, INC | June 16, 2026 | To approve the amendment to the Amended and Restated 2014 Equity Incentive Award Plan, or the Restated Plan, to increase the maximum number of shares of common stock that may be delivered pursuant to awards granted under the Restated Plan by 9,000,000 shares. Compensation |
Board | For | AGAINST 3 funds |
Split 1 AGAINST, 1 ABSTAIN |
| ARDELYX, INC | June 16, 2026 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the proxy statement accompanying this notice pursuant to the compensation disclosure rules of the Securities and Exchange Commission (''Say-on-Pay''); Say-on-Pay |
Board | For | FOR 5 funds |
Split 1 FOR, 1 ABSTAIN |
| ARDELYX, INC | June 16, 2026 | To ratify the appointment, by the Audit and Compliance Committee of our Board of Directors, of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026; and Audit-related |
Board | For | FOR 3 funds |
Split 1 FOR, 1 ABSTAIN |
| ARES MANAGEMENT CORPORATION | June 8, 2026 | The ratification of the selection of Ernst & Young LLP as our independent registered public accounting firm for our 2026 fiscal year. Audit-related |
Board | For | FOR 8 funds |
Split 4 FOR, 2 ABSTAIN |
| ARGAN, INC. | June 10, 2026 | The ratification of the appointment of Grant Thornton LLP as our independent registered public accountants for the fiscal year ending January 31, 2027. Audit-related |
Board | For | FOR 6 funds |
Split 4 FOR, 2 ABSTAIN |
| ARHAUS, INC. | May 14, 2026 | To approve the selection of PricewaterhouseCoopers LLP as the Company's independent accountants for the Company's fiscal year ending December 31, 2026; Audit-related |
Board | For | FOR 3 funds |
Split 1 FOR, 1 ABSTAIN |
| ARISTA NETWORKS, INC. | May 29, 2026 | Approval, on an advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 3 FOR, 10 AGAINST |
Split 4 FOR, 5 AGAINST, 5 ABSTAIN |
| ARISTA NETWORKS, INC. | May 29, 2026 | Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 10 funds |
Split 9 FOR, 5 ABSTAIN |
| ARKO CORP | June 4, 2026 | Approval of a non-binding advisory resolution regarding the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | Split 5 FOR, 1 AGAINST |
FOR 3 funds |
| ARMSTRONG WORLD INDUSTRIES, INC. | June 11, 2026 | To approve, on an advisory basis, our executive compensation program. Say-on-Pay |
Board | For | FOR 5 funds |
Split 5 FOR, 1 ABSTAIN |
| ARMSTRONG WORLD INDUSTRIES, INC. | June 11, 2026 | To ratify the selection of KPMG LLP as our independent registered public accounting firm for 2026. Audit-related |
Board | For | FOR 3 funds |
Split 4 FOR, 1 AGAINST, 1 ABSTAIN |
| ARRAY DIGITAL INFRASTRUCTURE, INC. | October 9, 2025 | Advisory vote to approve executive compensation Say-on-Pay |
Board | For | Split 2 FOR, 2 AGAINST |
AGAINST 1 fund |
| ARROW ELECTRONICS, INC. | May 12, 2026 | To approve, by non-binding vote, named executive officer compensation. Say-on-Pay |
Board | For | FOR 9 funds |
Split 2 FOR, 2 ABSTAIN |
| ARROW ELECTRONICS, INC. | May 12, 2026 | To ratify the appointment of Ernst & Young LLP as Arrow's independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 7 funds |
Split 2 FOR, 2 ABSTAIN |
| ARROWHEAD PHARMACEUTICALS, INC. | March 19, 2026 | Advisory Vote to Approve Executive Compensation. Say-on-Pay |
Board | For | AGAINST 6 funds |
Split 4 AGAINST, 2 ABSTAIN |
| ARROWHEAD PHARMACEUTICALS, INC. | March 19, 2026 | Approval of the Arrowhead Pharmaceuticals, Inc. Amended and Restated 2021 Incentive Plan. Compensation |
Board | For | FOR 4 funds |
Split 4 FOR, 2 ABSTAIN |
| ARROWHEAD PHARMACEUTICALS, INC. | March 19, 2026 | Ratification of the selection of KPMG LLP as independent auditors of the Company for the fiscal year ending September 30, 2026. Audit-related |
Board | For | FOR 4 funds |
Split 4 FOR, 2 ABSTAIN |
| ARTERIS, INC. | June 2, 2026 | To ratify the appointment by the Audit Committee of the Company's Board of Directors, of Deloitte & Touche LLP, as the independent registered public accounting firm and independent auditor for its year ending December 31, 2026; Audit-related |
Board | For | FOR 3 funds |
Split 4 FOR, 1 ABSTAIN |
| ARTHUR J. GALLAGHER & CO. | May 12, 2026 | Approval, on an Advisory Basis, of the Compensation of our Named Executive Officers. Say-on-Pay |
Board | For | FOR 14 funds |
Split 3 FOR, 1 AGAINST, 2 ABSTAIN |
| ARTHUR J. GALLAGHER & CO. | May 12, 2026 | Ratification of the Appointment of Ernst & Young LLP as our Independent Auditor for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 11 funds |
Split 4 FOR, 2 ABSTAIN |
| ARVINAS, INC. | June 24, 2026 | Ratification of the appointment of Deloitte & Touche LLP as the Company's Independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 3 funds |
Split 2 FOR, 1 ABSTAIN |
| ARVINAS, INC. | June 24, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 5 funds |
Split 2 FOR, 1 ABSTAIN |
| ASANA, INC. | June 8, 2026 | Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending January 31, 2027. Audit-related |
Board | For | FOR 3 funds |
Split 2 FOR, 1 ABSTAIN |
| ASBURY AUTOMOTIVE GROUP, INC. | May 4, 2026 | Approval, on an advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 7 funds |
Split 5 FOR, 1 ABSTAIN |
| ASBURY AUTOMOTIVE GROUP, INC. | May 4, 2026 | Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | FOR 5 funds |
Split 5 FOR, 1 ABSTAIN |
| ASCENDIS PHARMA A S | March 23, 2026 | Election of State-authorized Public Auditor Audit-related |
Board | For | FOR 3 funds |
Split 2 FOR, 2 ABSTAIN |
| ASCENDIS PHARMA A S | March 23, 2026 | Resolution on Application of Profits or Covering of Losses as per the Adopted Annual Report Corporate Governance |
Board | For | FOR 3 funds |
Split 2 FOR, 2 ABSTAIN |
| ASHLAND INC. | January 20, 2026 | ELECTION OF DIRECTORS: Ashish K. Kulkarni Director Elections |
Board | For | FOR 4 funds |
Split 2 FOR, 1 ABSTAIN |
| ASHLAND INC. | January 20, 2026 | ELECTION OF DIRECTORS: Guillermo Novo Director Elections |
Board | For | FOR 4 funds |
Split 2 FOR, 1 ABSTAIN |
| ASHLAND INC. | January 20, 2026 | ELECTION OF DIRECTORS: Jerome A. Peribere Director Elections |
Board | For | FOR 4 funds |
Split 2 FOR, 1 ABSTAIN |
| ASHLAND INC. | January 20, 2026 | ELECTION OF DIRECTORS: Sanat Chattopadhyay Director Elections |
Board | For | FOR 4 funds |
Split 2 FOR, 1 ABSTAIN |
| ASHLAND INC. | January 20, 2026 | ELECTION OF DIRECTORS: Scott A. Tozier Director Elections |
Board | For | FOR 4 funds |
Split 2 FOR, 1 ABSTAIN |
| ASHLAND INC. | January 20, 2026 | ELECTION OF DIRECTORS: Steven D. Bishop Director Elections |
Board | For | FOR 4 funds |
Split 2 FOR, 1 ABSTAIN |
| ASHLAND INC. | January 20, 2026 | ELECTION OF DIRECTORS: Susan L. Main Director Elections |
Board | For | FOR 4 funds |
Split 2 FOR, 1 ABSTAIN |
| ASHLAND INC. | January 20, 2026 | ELECTION OF DIRECTORS: Suzan F. Harrison Director Elections |
Board | For | FOR 4 funds |
Split 2 FOR, 1 ABSTAIN |
| ASSA ABLOY AB | April 28, 2026 | Approve Remuneration Report Compensation |
Board | For | FOR 3 funds |
Split 2 FOR, 1 AGAINST |
| ASSA ABLOY AB | April 28, 2026 | Reelect Johan Hjertonsson (Chair), Carl Douglas (Vice Chair), Erik Ekudden, Sofia Schorling Hogberg, Lena Olving, Victoria Van Camp and Susanne Pahlen Aklundh as Directors; Elect Astrid Mozes and Jurgen Timperman as New Directors Director Elections |
Board | For | AGAINST 3 funds |
Split 1 FOR, 2 AGAINST |
| ASSOCIATED BANC-CORP | April 28, 2026 | Advisory approval of Associated Banc-Corp's named executive officer compensation. Say-on-Pay |
Board | For | FOR 8 funds |
Split 6 FOR, 1 ABSTAIN |
| ASSOCIATED BANC-CORP | April 28, 2026 | The ratification of the selection of KPMG LLP as the independent registered public accounting firm for Associated Banc-Corp for the year ending December 31, 2026. Audit-related |
Board | For | FOR 6 funds |
Split 6 FOR, 1 ABSTAIN |
| ASSURANT, INC. | May 21, 2026 | Advisory approval of the fiscal year 2025 compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 13 funds |
Split 5 FOR, 1 AGAINST, 1 ABSTAIN |
| ASSURANT, INC. | May 21, 2026 | Approval of an amendment to the Assurant, Inc. 2017 long term equity incentive plan. Compensation |
Board | For | FOR 10 funds |
Split 6 FOR, 1 ABSTAIN |
| ASSURANT, INC. | May 21, 2026 | Election of Directors: Elaine D. Rosen Director Elections |
Board | For | FOR 10 funds |
Split 6 FOR, 1 ABSTAIN |
| ASSURANT, INC. | May 21, 2026 | Election of Directors: Harriet Edelman Director Elections |
Board | For | FOR 10 funds |
Split 6 FOR, 1 ABSTAIN |
| ASSURANT, INC. | May 21, 2026 | Election of Directors: J. Braxton Carter Director Elections |
Board | For | FOR 10 funds |
Split 6 FOR, 1 ABSTAIN |
| ASSURANT, INC. | May 21, 2026 | Election of Directors: Keith W. Demmings Director Elections |
Board | For | FOR 10 funds |
Split 6 FOR, 1 ABSTAIN |
| ASSURANT, INC. | May 21, 2026 | Election of Directors: Kevin M. Warren Director Elections |
Board | For | FOR 10 funds |
Split 6 FOR, 1 ABSTAIN |
| ASSURANT, INC. | May 21, 2026 | Election of Directors: Lynn S. Blake Director Elections |
Board | For | FOR 10 funds |
Split 6 FOR, 1 ABSTAIN |
| ASSURANT, INC. | May 21, 2026 | Election of Directors: Ognjen (Ogi) Redzic Director Elections |
Board | For | FOR 10 funds |
Split 6 FOR, 1 ABSTAIN |
| ASSURANT, INC. | May 21, 2026 | Election of Directors: Paul J. Reilly Director Elections |
Board | For | FOR 10 funds |
Split 6 FOR, 1 ABSTAIN |
| ASSURANT, INC. | May 21, 2026 | Election of Directors: Rajiv Basu Director Elections |
Board | For | FOR 10 funds |
Split 6 FOR, 1 ABSTAIN |
| ASSURANT, INC. | May 21, 2026 | Election of Directors: Sari Granat Director Elections |
Board | For | FOR 10 funds |
Split 6 FOR, 1 ABSTAIN |
| ASSURANT, INC. | May 21, 2026 | Ratification of the appointment of PricewaterhouseCoopers LLP as Assurant's independent registered public accounting firm for fiscal year 2026. Audit-related |
Board | For | FOR 10 funds |
Split 6 FOR, 1 ABSTAIN |
| ASSURED GUARANTY LTD. | May 1, 2026 | Appointment of PricewaterhouseCoopers LLP as the Company's independent auditor for the fiscal year ending December 31, 2026 and authorization of the Board of Directors, acting through its Audit Committee, to set the fees for the independent auditor Audit-related |
Board | For | FOR 4 funds |
Split 2 FOR, 1 ABSTAIN |
| AST SPACEMOBILE, INC. | November 21, 2025 | To approve the Amended and Restated AST SpaceMobile, Inc. 2024 Incentive Award Plan to increase the number of shares of the Company's Class A Common Stock available for issuance thereunder and to extend the term of the plan. Compensation |
Board | For | AGAINST 3 funds |
Split 2 AGAINST, 1 ABSTAIN |
| AST SPACEMOBILE, INC. | June 12, 2026 | To approve the non-binding advisory resolution on the compensation paid to the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 6 funds |
Split 1 FOR, 2 AGAINST, 1 ABSTAIN |
| AST SPACEMOBILE, INC. | June 12, 2026 | To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for fiscal year 2026. Audit-related |
Board | For | FOR 4 funds |
Split 3 FOR, 1 ABSTAIN |
| ASTERA LABS, INC. | June 4, 2026 | To approve, on an advisory basis, the compensation of our named executive officers ("NEOs") as disclosed in our proxy materials. Say-on-Pay |
Board | For | FOR 6 funds |
Split 3 FOR, 1 AGAINST |
| ASTERA LABS, INC. | June 4, 2026 | To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 4 funds |
Split 4 FOR, 2 ABSTAIN |
| ASTRANA HEALTH, INC. | June 10, 2026 | To approve the Astrana Health, Inc. Amended and Restated 2024 Equity Incentive Plan. Compensation |
Board | For | FOR 4 funds |
Split 2 FOR, 1 ABSTAIN |
| ASTRANA HEALTH, INC. | June 10, 2026 | To approve, on a non-binding advisory basis, the compensation program for the Company's named executive officers as disclosed in the Company's proxy statement. Say-on-Pay |
Board | For | FOR 6 funds |
Split 2 FOR, 1 ABSTAIN |
| ASTRANA HEALTH, INC. | June 10, 2026 | To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 4 funds |
Split 2 FOR, 1 ABSTAIN |
| ASTRIA THERAPEUTICS, INC. | January 21, 2026 | To cast a vote, on a non-binding, advisory basis, to approve the Merger-related named executive officer compensation as disclosed in the table entitled ''Golden Parachute Compensation'' and its accompanying footnotes which is included in the section of the proxy statement entitled ''The Merger-Interests of Astia's Directors and Executive Officers in the Merger,'' as required by Section 14A of the Securities Exchange Act of 1934, as amended, which was enacted as part of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010. Say-on-Pay |
Board | For | FOR 5 funds |
Split 1 FOR, 1 ABSTAIN |
| ASTRONICS CORPORATION | May 28, 2026 | To approve the adoption of the Astronics Corporation 2026 Employee Stock Purchase Plan. Compensation |
Board | For | FOR 3 funds |
Split 2 FOR, 1 AGAINST |
| ASTRONICS CORPORATION | May 28, 2026 | To approve the advisory resolution indicating the approval of the Compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 5 funds |
Split 2 FOR, 1 ABSTAIN |
| ASTRONICS CORPORATION | May 28, 2026 | To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 3 funds |
Split 2 FOR, 1 ABSTAIN |
| AT&T INC | May 14, 2026 | Advisory approval of executive compensation Say-on-Pay |
Board | For | FOR 11 funds |
Split 5 FOR, 1 AGAINST, 6 ABSTAIN |
| AT&T INC. | May 14, 2026 | Election of Directors: Beth E. Mooney Director Elections |
Board | For | FOR 8 funds |
Split 5 FOR, 6 ABSTAIN |
| AT&T INC. | May 14, 2026 | Election of Directors: Cynthia B. Taylor Director Elections |
Board | For | FOR 8 funds |
Split 5 FOR, 6 ABSTAIN |
| AT&T INC. | May 14, 2026 | Election of Directors: John T. Stankey Director Elections |
Board | For | FOR 8 funds |
Split 5 FOR, 6 ABSTAIN |
| AT&T INC. | May 14, 2026 | Election of Directors: Kelly J. Grier Director Elections |
Board | For | FOR 8 funds |
Split 5 FOR, 6 ABSTAIN |
| AT&T INC. | May 14, 2026 | Election of Directors: Marissa A. Mayer Director Elections |
Board | For | FOR 8 funds |
Split 5 FOR, 6 ABSTAIN |
| AT&T INC. | May 14, 2026 | Election of Directors: Matthew K. Rose Director Elections |
Board | For | FOR 8 funds |
Split 5 FOR, 6 ABSTAIN |
| AT&T INC. | May 14, 2026 | Election of Directors: Michael B. McCallister Director Elections |
Board | For | FOR 8 funds |
Split 5 FOR, 6 ABSTAIN |
| AT&T INC. | May 14, 2026 | Election of Directors: Stephen J. Luczo Director Elections |
Board | For | FOR 8 funds |
Split 5 FOR, 6 ABSTAIN |
| AT&T INC. | May 14, 2026 | Election of Directors: William E. Kennard Director Elections |
Board | For | FOR 8 funds |
Split 5 FOR, 6 ABSTAIN |
| AT&T INC. | May 14, 2026 | Ratification of the Appointment of Ernst & Young LLP as Independent Auditors Audit-related |
Board | For | FOR 8 funds |
Split 5 FOR, 1 AGAINST, 6 ABSTAIN |
| ATEA PHARMACEUTICALS, INC. | June 18, 2026 | Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company. Say-on-Pay |
Board | For | FOR 5 funds |
Split 3 FOR, 1 ABSTAIN |
| ATI INC. | May 14, 2026 | Advisory vote to approve the compensation of our named executive officers Say-on-Pay |
Board | For | FOR 7 funds |
Split 7 FOR, 2 ABSTAIN |
| ATI INC. | May 14, 2026 | Election of Directors: David J. Morehouse Director Elections |
Board | For | FOR 5 funds |
Split 5 FOR, 4 WITHHOLD |
| ATI INC. | May 14, 2026 | Election of Directors: Elizabeth H. Lund Director Elections |
Board | For | FOR 5 funds |
Split 7 FOR, 2 WITHHOLD |
| ATI INC. | May 14, 2026 | Election of Directors: Kimberly A. Fields Director Elections |
Board | For | FOR 5 funds |
Split 7 FOR, 2 WITHHOLD |
| ATI INC. | May 14, 2026 | Ratification of the election of Ernst & Young LLP as our independent auditors for 2026 Audit-related |
Board | For | FOR 5 funds |
Split 6 FOR, 1 AGAINST, 2 ABSTAIN |
| ATLANTIC UNION BANKSHARES CORPORATION | May 5, 2026 | To elect directors to serve until the 2027 annual meeting of shareholders: Daniel J. Schrider Director Elections |
Board | For | FOR 5 funds |
Split 2 FOR, 1 ABSTAIN |
| ATLANTIC UNION BANKSHARES CORPORATION | May 5, 2026 | To elect directors to serve until the 2027 annual meeting of shareholders: Donald R. Kimble Director Elections |
Board | For | FOR 5 funds |
Split 2 FOR, 1 ABSTAIN |
| ATLANTIC UNION BANKSHARES CORPORATION | May 5, 2026 | To elect directors to serve until the 2027 annual meeting of shareholders: F. Blair Wimbush Director Elections |
Board | For | FOR 5 funds |
Split 2 FOR, 1 ABSTAIN |
← Previous Page 6 of 62 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 25, 2026 from SEC Form N-PX filings.